Colchicine in Periprocedural Myocardial Infarction: the Role of Alpha Defensin

• Status: Unknown status
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this research is to study the effect of a loading dose of colchicine on the occurrence of periprocedural myocardial infarction (PPMI) in elective percutaneous coronary intervention.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hillel Yaffe Medical Center
• Treatments: alpha-Defensins; Colchicine; Defensins

Criteria

Inclusion Criteria:

• Patients hospitalized with troponin negative events and scheduled for elective PCI

Exclusion Criteria:

• Significant renal dysfunction

• Significant liver dysfunction

• Severe left ventricular dysfunction

• Severe low weight

• Chronic colchicine treatment